| | | | |
CUSIP No. G2007L204 | | SCHEDULE 13D/A | | Page 8 of 11 Pages |
This Amendment No. 2 (“Amendment No. 2”) is being filed by Anson Funds Management LP (the “Investment Entity”), Anson Management GP LLC, Mr. Bruce R. Winson, Anson Advisors Inc., Mr. Amin Nathoo and Mr. Moez Kassam (collectively, the “Reporting Persons”) with respect to the ordinary shares, par value NIS 5.00 (the “Ordinary Shares” or the “Shares”) of Nano Dimension Ltd., a corporation incorporated under the laws of Israel (the “Issuer”). This Amendment No. 2 amends and supplements Amendment No. 1 filed with the Securities and Exchange Commission (the “SEC”) on May 1, 2023 (“Amendment No. 1”) and the Schedule 13D filed with the SEC on March 10, 2023 (the “Original Schedule 13D”, and together with Amendment No. 1 and this Amendment No. 2, the “Schedule 13D”). Except as specifically provided herein, this Amendment No. 2 does not modify any of the information previously reported in the Schedule 13D. Information in response to each item shall be deemed to be incorporated by reference in all other items. Capitalized terms used but not defined in this Amendment No. 2 shall have the meanings ascribed to such terms in the Schedule 13D.
Item 3. | Source and Amount of Funds or Other Considerations |
Item 3 of the Schedule 13D is amended and restated as follows:
The ADSs representing the Ordinary Shares reported herein as being beneficially owned by the Reporting Persons were purchased using working capital of the Funds. An aggregate of approximately $40,201,926.41 (excluding brokerage commissions) was used to purchase ADSs representing Ordinary Shares reported as beneficially owned by the Reporting Persons in this Schedule 13D. Such securities were acquired through open market purchases.
Item 4. | Purpose of Transaction |
Item 4 of the Schedule 13D is amended and supplemented to include the following:
On June 22, 2023, the Issuer filed an amendment to its Complaint (the “Amended Complaint”) against the Reporting Person Defendants and Other Defendants. A copy of the Amended Complaint, together with a redline against the original Complaint, is filed herewith as Exhibit 99.3 and incorporated herein by reference, and any descriptions herein of the Amended Complaint are qualified in their entirety by reference to the Amended Complaint. The Reporting Persons believe that the allegations contained in the Amended Complaint, just like those contained in the original Complaint, are without merit and intend to defend themselves vigorously.
Exhibit 99.3 includes a copy of the Amended Complaint, but excludes the exhibits appended to the Amended Complaint. Exhibit 1 to the Amended Complaint is incorporated herein by reference to the Schedule 13D filed with the SEC by the Other Defendants on January 23, 2023 and the Schedule 13D/As filed by the Other Defendants on February 13, 2023, March 6, 2023, and May 2, 2023. Exhibit 2 to the Amended Complaint is incorporated herein by reference to the Schedule 13D filed with the SEC by the Reporting Persons on March 10, 2023 the Schedule 13D/A filed by the Reporting Persons on May 1, 2023. Exhibit 3 to the Amended Complaint is incorporated herein by reference to the Amended and Restated Form of Depositary Agreement, dated as of April 15, 2019, among Nano Dimension Ltd., The Bank of New York Mellon as Depositary, and owners and holders from time to time of ADSs issued thereunder, including the Form of American Depositary Shares, filed as Exhibit 1 to the Form F-6 (File No. 333-252477) filed on January 27, 2021, and is incorporated herein by reference.